Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the earnings conference call held on May 21, 202427-05-2024
27-05-2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform that the officials of the Company will be meeting Investors/Analysts (Participants) on May 30, 202422-05-2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Audio Recording of Earnings Call dated May 21, 2024.21-05-2024
FY24 Annual Result Announced for Krsnaa Diagnostics Ltd.
Healthcare Services company Krsnaa Diagnostics announced FY24 results: Revenue from Operations: Rs 6,196 million, up 27% YoY EBITDA: Rs 1,461 million, representing an 18% YoY growth with a 24% margin Profit After Tax: Rs 568 million Commenting on the business, Yash Mutha, Joint Managing Director, said: “I am pleased to announce the outstanding results for the quarter and financial year 2024 which align with our strategic growth plans. Krsnaa Diagnostics is uniquely positioned to capitalize on the burgeoning growth trends in diagnostics Industry. We are thrilled to announce a historic milestone in India: Krsnaa Diagnostics is the first ever lab operating in a government location to receive the prestigious CAP accreditation, setting a new benchmark for excellence in the industry. The CAP accreditation is a testament to our commitment to quality and excellence in diagnostic services. We have recently secured a significant agreement with the Maharashtra Government for the installation and operation of 17 MRI and 17 CT machines, which is India’s one of the largest MRI tenders and further cements our leadership in the industry. We are excited to welcome Mr. Mitesh Dave as Group CEO, with him at helm we are poised to accelerate our penetration into the B2C market. We are confident that under Mitesh’s leadership, Krsnaa Diagnostics will continue to set new benchmarks in the diagnostics industry, delivering exceptional value to our stakeholders and enhancing our market position.” Commenting on the business, Pallavi Bhatevara, Executive Director, said: “Indian Healthcare ecosystem stands to benefit from structural tailwinds like increased consumer awareness, favorable demographics, rise in lifestyle related diseases, and strong thrust towards infrastructure from the public sector. India’s healthcare expenditure - only 3% of GDP has historically remained suppressed vs. global peers owing to higher ‘out of pocket’ expenses and lower health insurance penetration. Krsnaa Diagnostics continues to play a major role in providing high-quality and affordable diagnostic services. The provision of high-quality and affordable diagnostic services stands as a fundamental pillar within the healthcare industry. At present, Krsnaa Diagnostics is well-positioned to deploy 67 CT Scan machine, 23 MRI machine, establish 162 labs and set up 3,153 collection centers, all under various contractual agreements. These recent contract wins underscore the exceptional capabilities of our in-house teams, reflecting their proficiency in navigating the intricate bidding process, meeting all necessary requirements, and ultimately securing these contracts. As we embark on these projects, Krsnaa Diagnostics is actively expanding its footprint into new geographical regions, establishing a solid foundation for sustainable, long-term growth.” Result PDF20-05-2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication pertaining to the Audited (Standalone and Consolidated) Financial results for the quarter and year ended March 31, 2024.20-05-2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Analyst / Institutional Investor Meeting scheduled to be held on May 21, 2024 at 18:00 Hrs. (I.S.T.)20-05-2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of the Securities and Board of India (Listing Obligation and Disclosure Requirements), 2015, we are enclosing herewith a copy of the presentation for the Investor/Analysts on Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2024.19-05-2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release- Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2024.18-05-2024
Krsnaa Diagnostics Ltd - 543328 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2024 issued by M/S Dinesh Birla and Associates, Company Secretaries.18-05-2024
Krsnaa Diagnostics Ltd - 543328 - Announcement under Regulation 30 (LODR)-Change in Management
Disclosure under Regulation 30 of SEBI (LODR), 2015- Appointment of Group Chief Executive Office of the Company.18-05-2024